Related Experiment Video
Updated: May 22, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Genetic susceptibility to atherosclerosis.
Sanja Kovacic1, Mirjana Bakran
1Department of Neurology, General Hospital Zabok, Zabok, Croatia.
Stroke Research and Treatment
|May 3, 2012
Summary
Genetic factors significantly influence atherosclerosis susceptibility. Future research aims to identify predisposed individuals early and discover new drug targets for this complex arterial disease.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Genomics
Background:
- Atherosclerosis is a complex arterial disease influenced by genetic and environmental factors.
- Molecular genetics advances highlight the significant role of genetic predisposition in atherosclerotic vascular diseases.
- Numerous candidate genes, genetic polymorphisms, and susceptibility loci for atherosclerosis have been identified.
Purpose of the Study:
- To review the main genetic investigation fields related to human atherosclerotic vascular diseases.
- To discuss future directions and implications of genetic research in arteriosclerosis.
- To emphasize early prediction of individuals predisposed to premature atherosclerosis and novel drug target discovery.
Main Methods:
- Review of current literature on genetic investigations in atherosclerosis.
- Analysis of identified genetic factors, polymorphisms, and susceptibility loci.
- Discussion of prospective genetic screening and therapeutic target identification.
Main Results:
- Genetic factors play a crucial role in determining susceptibility to atherosclerosis.
- A growing number of genetic markers are associated with atherosclerotic diseases.
- Future research holds promise for early risk prediction and novel therapeutic strategies.
Conclusions:
- Genetic research is pivotal in understanding and managing atherosclerosis.
- Early identification of genetic predisposition can enable preventative strategies.
- Further genetic insights will facilitate the development of targeted therapies for atherosclerosis.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...